Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05615298 · ClinicalTrials.gov registry record
Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer
A clinical trial, sponsored by Lunit.
- Completed
- Registry status
- 240
- Enrollment target
NCT05615298: Completed study, sponsored by Lunit.
NCT05615298 is a clinical trial that has completed, run by Lunit. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05615298 has completed, sponsored by Lunit.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This study aims to evaluate Effectiveness of Investigational Device, Lunit INSIGHT MMG, in the assistance of Detection and Diagnosis of Breast Cancer during Screening Mammography Interpretation.
Primary Outcome
Patient-level FBR (forced BI-RADS) area under the Receiver Operating Characteristic (ROC) curve to measure the effectiveness of Investigational Device between CAD assited and unassisted environment
Interventions
- RADIATION Mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2021-01-13 |
What the finished NCT05615298 record still lists
NCT05615298 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Mammography is the first listed.
NCT05615298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05615298 about?
NCT05615298 is a clinical study titled "Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer". This study aims to evaluate Effectiveness of Investigational Device, Lunit INSIGHT MMG, in the assistance of Detection and Diagnosis of Breast Cancer during Screening Mammography Interpretation.
What is the current status of trial NCT05615298?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2020-06-15. Estimated completion is 2021-01-13.
What interventions are being tested in trial NCT05615298?
The interventions under investigation include: Mammography (RADIATION).
Who is sponsoring clinical trial NCT05615298?
This trial is sponsored by Lunit, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI